Business · 18/01/2017

FDA Clears SYMMETREL Syrup for Continued Sale

The US Food and Drug Administration (FDA) has ruled that SYMMETREL syrup, containing 50 milligrams of amantadine hydrochloride per 5 milliliters, was not withdrawn from sale due to safety or effectiveness concerns. This decision means the FDA will not initiate procedures to revoke SYMMETREL's approval and will continue to approve new drug applications referencing the product if all applicable regulations are met.